Alnylam Pharmaceuticals
HealthcareBiotech & Pharma
HQ: Cambridge, USA
Investors: 1
A biopharmaceutical company focused on the discovery and development of RNA interference therapeutics.
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| Blackstone | Current | - | - | - |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get Signals